Related references
Note: Only part of the references are listed.Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial
Anne Montfort et al.
CLINICAL CANCER RESEARCH (2021)
TRAIL of Hope Meeting Resistance in Cancer
David Deng et al.
TRENDS IN CANCER (2020)
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Julian Staniek et al.
FRONTIERS IN IMMUNOLOGY (2019)
The TNF Paradox in Cancer Progression and Immunotherapy
Anne Montfort et al.
FRONTIERS IN IMMUNOLOGY (2019)
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
Fei Yi et al.
TRENDS IN MOLECULAR MEDICINE (2018)
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors
Michele Vigolo et al.
NATURE COMMUNICATIONS (2018)
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling
Cristian R. Smulski et al.
CELL DEATH & DISEASE (2017)
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Florie Bertrand et al.
NATURE COMMUNICATIONS (2017)
BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells
Cristian R. Smulski et al.
CELL REPORTS (2017)
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
Florent Dufour et al.
CELL DEATH AND DIFFERENTIATION (2017)
More to Life than NF-κB in TNFR1 Signaling
Adrian T. Ting et al.
TRENDS IN IMMUNOLOGY (2016)
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Sarah A. Laurent et al.
NATURE COMMUNICATIONS (2015)
The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Franziska S. Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2015)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)
TG Cachero et al.
BIOCHEMISTRY (2006)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Share Paper
